Symptoms of mental disorders during the COVID-19 pandemic in Latin America – a systematic review and meta-analysis

This article was originally published here

Epidemiol Psychiatr Sci. 2022 April 19;31:e23. doi: 10.1017/S2045796021000767.


OBJECTIVES: There is a lack of evidence related to the prevalence of mental health symptoms as well as their heterogeneities during the coronavirus disease 2019 (COVID-19) pandemic in Latin America, a large area spanning the equator. The current study aims to provide meta-analytic evidence on mental health symptoms during COVID-19 among frontline healthcare workers, general healthcare workers, the general population, and university students in America. Latin.

METHODS: Bibliographic databases, such as PubMed, Embase, Web of Science, PsycINFO and medRxiv, were systematically searched to identify relevant studies up to August 13, 2021. Two coders performed the selection using criteria of predefined eligibility. Quality scores were assigned to studies using the mixed methods assessment tool. The double data extraction method was used to minimize data entry errors.

RESULTS: A total of 62 studies with 196,950 participants in Latin America were identified. The combined prevalence of anxiety, depression, distress, and insomnia was 35%, 35%, 32%, and 35%, respectively. There was a higher prevalence of mental health symptoms in South America compared to Central America (36% versus 28%, p

CONCLUSIONS: The high but heterogeneous level of prevalence of mental health symptoms highlights the need for proper identification of psychological interventions in Latin America.

PMID:35438066 | DOI:10.1017/S2045796021000767

Comments are closed.